ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Seeks Nominations For Consumer Liaison Group.

November 23, 2001

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits

March 14, 2003

In Congress: Senate Bill Offers 13% Increase For NCI; house Provides 9%

October 8, 1999

NCI advisors approve new grants programs. NCI funds consortium of cohorts. Funding opportunities listed.

August 1, 2003

SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis.

April 30, 2004